Digital Health Global

NOVEMBER 20, 2023

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. Please visit astrazeneca.com and follow the Company on Social Media @ AstraZeneca.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Digital Health Global

OCTOBER 13, 2023

.–(BUSINESS WIRE)–BIOQuébec and BioFlorida, preeminent life sciences associations from Québec and Florida, are proud to announce the signing of a Memorandum of Understanding (MOU). Fostering global connections and innovation and fueling growth are key to advancing the life sciences industry in Florida,” said Nancy K.

Life Science 88

Life Science BioTech Digital Health 88

Healthcare IT Today

OCTOBER 24, 2024

In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and life sciences sectors.

Life Science 120

Life Science Leadership BioTech Connected Health 120

Digital Health Global

MARCH 27, 2024

Supreme Group is a healthcare commercialization platform company formed following Trinity Hunt’s majority investment in Supreme Optimization , a leading life science-focused digital agency. We look forward to supporting the agency as it continues on its growth trajectory.” For more information, visit www.trinityhunt.com.

Life Science 88

Life Science BioTech Leadership Digital Health 88

Mobi Health News

OCTOBER 18, 2019

This week at the Connected Health Conference in Boston, Bob Coughlin, executive director of the Mass Biotech Council and Dr. Joe Kvedar, VP of Connected Health at Partners, talked the future of digital in life sciences.

Life Science 117

Life Science BioTech Connected Health 117

Digital Health Global

APRIL 15, 2024

EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing. They are, however, fully owned and operated by EVERSANA.

Life Science 88

Life Science Pharmaceuticals BioTech Digital Health 88

Healthcare IT Today

APRIL 4, 2023

The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and life sciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.

Life Science 110

Life Science BioTech Pharmaceuticals Public Health 110

Digital Health Global

OCTOBER 11, 2023

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. .

Life Science 167

Life Science Pharmaceuticals BioTech Leadership 167

Healthcare IT Today

MARCH 22, 2023

The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.

Life Science 110

Life Science BioTech EHR Healthcare IT 110

Digital Health Global

FEBRUARY 5, 2024

Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science. Solas puts patients first.

Life Science 88

Life Science Pharmaceuticals Medical Technology BioTech 88

Digital Health Global

APRIL 17, 2024

This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digital health, medical devices, life sciences, and tech-enabled care delivery. OpenLoop : An end-to-end telemedicine enablement company surpassed $100 million in annualized revenues in early 2024.

Life Science 88

Life Science BioTech Healthcare Innovation Digital Health 88

Health Populi

APRIL 24, 2018

Biotech is roughly tied for second place with consumer health, dropping also by 7 points. There’s another piece of math worth doing here: a chasm between biotech and pharma of 17 percentage points worth of trust — that is the difference between the 55% of American trusting biotech versus 38% trusting pharma.

BioTech 185

BioTech Life Science Nursing Mental health 185

Healthcare IT Today

APRIL 25, 2024

Reflecting on AION Lab’s role in nurturing biotech startups, Gill underscores the company’s commitment to fostering innovation and supporting the growth of emerging ventures. Check our our video interview below to learn more about AION Labs approach to innovation in pharma and life sciences.

Pharmaceuticals 135

Pharmaceuticals Drug Development BioTech Life Science 135

Healthcare IT Today

SEPTEMBER 13, 2024

The round was led by Eventide Asset Management (Eventide), which invests in biotech and life science healthcare companies seeking solutions for unmet clinical needs. million in Series B funding, bringing its total funding to date to $31.5

Life Science 118

Life Science BioTech Health IT Healthcare IT 118

Digital Health Global

APRIL 3, 2023

Hyman, MD, Director, Stanley Center for Psychiatric Research at the Broad Institute and Co-Chair of the Wyss Center Executive Board: “Erwin is a pioneer in life science research and a visionary and experienced leader in translating promising technologies to improve patient care. Professor Steven E.

BioTech 88

BioTech Life Science Mental health Digital Health 88

Digital Health Global

MARCH 16, 2023

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

JANUARY 23, 2024

Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,

Drug Development 117

Drug Development Pharmaceuticals Life Science BioTech 117

Health Populi

JULY 11, 2019

Note that Cigna acquired Express Scripts, the pharmacy benefit management company, last year which was the health insurance company’s on-ramp to life sciences. The objective of this investment round is to further scale GNS solutions that personalize medicines to individual patients.

Life Science 228

Life Science BioTech Medicare Pharmaceuticals 228

Digital Health Global

JUNE 20, 2023

Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. She is passionate about the intersection of life science and technology and was drawn to Turbine for its distinction as a life sciences disruptor founded outside of the United States.

BioTech 88

BioTech Life Science Leadership Drug Development 88

Digital Health Global

DECEMBER 5, 2023

This infusion of capital, supported by new investor Bpifrance (through its InnoBio 2 fund), and existing backers Khosla Ventures and Seventure Partners (with Health For Life Capital ), propels Eligo towards becoming a clinical-stage biotech. Concurrent with this financing, Laia Crespo, Ph.D., Partner at Sanofi Ventures.

Life Science 88

Life Science BioTech Digital Health 88

Digital Health Global

MARCH 2, 2023

This synergistic partnership is a combination of resources, talent and expertise across two leading science-based organizations with a mission of optimizing and accelerating therapies for patients in need, through greater adoption of digital biomarkers in clinical studies,” said Vik Shah, President and COO of Koneksa.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

AUGUST 30, 2023

QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. We see a great need in the sector, and a shift in how pharma and biotech companies consume and innovate with AI with platforms such as QuantHealth, and we expect that shift to accelerate.”

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care.

BioTech 127

BioTech Life Science Drug Development Patient Experience 127

Lloyd Price

SEPTEMBER 2, 2023

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.

Life Science 67

Life Science Digital Health EHR BioTech 67

Digital Health Global

NOVEMBER 30, 2023

AstraZeneca has launched Evinova , an healthtech business focusing on providing digital solutions for clinical trials in the life sciences sector. The company will supply solutions to AstraZeneca while extending services to pharma, biotech companies, and clinical research organizations.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

APRIL 10, 2023

–(BUSINESS WIRE)– Aviceda Therapeutics , a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (Queen’s). CAMBRIDGE, Mass.–(BUSINESS

Life Science 88

Life Science BioTech Drug Development Health science 88

Health Populi

FEBRUARY 24, 2020

And note how Americans’ trust in hospitals — historically the top-trusted health care segment in the nation — eroded from 2018, tying with consumer health companies, and just north of biotech and life science organizations. Even trust with pharmaceutical companies increased that year.

Medical Billing 240

Medical Billing Digital Health Patient Experience Life Science 240

Healthcare IT Today

JANUARY 8, 2024

Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Ian Chan, CEO and Co-founder at Abpro The global supply chain issues and continued difficulties securing funding amid economic uncertainty caused challenges for many life sciences companies this year.

Health IT 116

Health IT Drug Development Pharmaceuticals BioTech 116

Digital Health Today

OCTOBER 16, 2019

The Connected Health Conference also promises an emphasis on the Life Sciences/BioTech and Digital Health, with sessions like the Fireside Chat on Pharma and Digital Health and Transforming the Life Sciences through Digital Health.

Connected Health 61

Connected Health Life Science BioTech Digital Health 61

Digital Health Today

NOVEMBER 28, 2023

The JP Morgan Healthcare Conference, often referred to simply as ‘JPM’, ‘JPM Week’, or ‘JPM Healthcare’, is an annual event that is considered one of the largest and most influential gatherings in the healthcare and life sciences industry. Who attends? The official JPM Conference held at The Westin St.

Life Science 52

Life Science BioTech Pharmaceuticals Healthcare Innovation 52

Health Populi

JUNE 24, 2021

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Digital Health Global

FEBRUARY 16, 2023

About RA Capital Management RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. For more information, please visit www.rac a p.com. Find out more: www.sanofiventures.com.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Healthcare IT Today

DECEMBER 17, 2019

Over the next five years, healthcare and life sciences firms will ramp up their digital transformation efforts, driven at least in part by AI and data analytics tools, according to a recent research report.

Life Science 73

Life Science BioTech EMR EHR 73

Health Populi

APRIL 24, 2019

In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. over-the-counter medicines); and, health insurance.

BioTech 208

BioTech Pharmaceuticals Life Science Health Information 208

Electronic Health Reporter

APRIL 3, 2019

a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1million on a Series C financing round. This article is copyrighted strictly for Electronic Health Reporter. Illegal copying is prohibited. Inanovate, Inc.,

Life Science 96

Life Science BioTech 96

Health Populi

MARCH 11, 2021

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

Health Policy 254

Health Policy Medicare Pharmaceuticals Life Science 254